Laboratory Evaluation for Loss of Height

Core Laboratory Tests

The American Heart Association recommends obtaining a comprehensive metabolic panel including serum calcium, phosphate, alkaline phosphatase, parathyroid hormone (PTH), 25-hydroxyvitamin D, thyroid-stimulating hormone (TSH), complete blood count, and consider iron studies to evaluate for osteoporosis, vertebral fractures, and metabolic bone disease in patients presenting with height loss 1, 2, 3
Complete blood count (CBC) should be drawn to assess for anemia and general hematologic status, as recommended by the American College of Cardiology 4, 2
Serum electrolytes including calcium and magnesium are critical for detecting hypocalcemia and parathyroid disorders, according to the American College of Cardiology 4, 2
Serum creatinine and blood urea nitrogen should be evaluated to assess renal function, which affects bone metabolism, as recommended by the American College of Cardiology 4, 2
Thyroid-stimulating hormone (TSH) should be checked to detect hypothyroidism, a well-established cause of growth impairment and bone health issues, as recommended by the American College of Cardiology 4, 2
25-hydroxyvitamin D level should be measured, as vitamin D deficiency is strongly associated with height loss and vertebral fractures, according to the European Society of Nuclear Medicine 1, 5

Alkaline phosphatase should be measured, as elevated levels suggest active bone disease or metabolic bone disorders, as recommended by the European Renal Association 6, 5
Parathyroid hormone (PTH) should be checked to detect hyperparathyroidism or secondary hyperparathyroidism from vitamin D deficiency, according to the European Renal Association 6, 5
Serum phosphate should be measured, as low levels may indicate phosphate wasting disorders or vitamin D deficiency, as recommended by the European Renal Association 6, 5

The European Society of Nuclear Medicine recommends that historical height loss >4 cm is a specific indication for vertebral fracture assessment, according to bone health guidelines 1
The American College of Rheumatology recommends that adults ≥40 years should undergo a comprehensive panel, with particular attention to bone metabolism markers 3
The American College of Rheumatology also recommends that postmenopausal women and men ≥50 years should undergo all listed tests as part of osteoporosis evaluation 3, 5

The Infectious Diseases Society of America recommends that vitamin D testing should not be skipped, as vitamin D deficiency is extremely common and directly contributes to height loss through vertebral fractures and osteomalacia 5
The American College of Cardiology recommends that thyroid function should not be overlooked, as subclinical hypothyroidism can impair growth and bone health, and treatment with levothyroxine significantly improves height velocity 4, 2
The European Renal Association recommends that calcium and PTH should be checked together, as checking only one can miss primary hyperparathyroidism or secondary hyperparathyroidism from vitamin D deficiency, both of which cause bone loss 6, 5

The American College of Rheumatology recommends that hypogonadism should be considered, and testosterone (men) or estradiol (women) should be measured if clinically indicated 3, 5
The Infectious Diseases Society of America recommends that malabsorption should be considered, and celiac serology should be measured if vitamin D deficiency is severe or refractory 5
The American College of Rheumatology recommends that glucocorticoid use should be documented, and cumulative steroid exposure should be measured 3

The 2022 AHA/ACC/HFSA guidelines recommend that this laboratory panel should be obtained to "optimize management" and identify treatable causes, according to the American Heart Association 2
The 2017 ACR guidelines recommend measuring height at each visit for patients on chronic glucocorticoids to detect early vertebral compression fractures, according to the American College of Rheumatology 3